References
- Araki M., Nanri H., Ejima K., Murasato Y., Fvijiwara T., Nakashima Y., Ikeda M. Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J. Biol. Chem. 1999; 274: 2271–2278
- Eklund H., Gleason F. K., Holmgren A. Structural and functional relations among thioredoxins of different species. Proteins: Structure, function and genetics 1991; 11: 13–28
- Heppell-Parton A., Cahn A., Bench A., Lowe N., Lehrach H., Zehetner G., Rabbitts P. Thioredoxin, a mediator of growth inhibition, maps to 9q31. Genomics 1995; 26: 379–381
- Holmgren A. Thioredoxin, Annu. Rev. Biochem. 1985; 54: 237–271
- Kaghad M., Dessarps R., Jacquemin-Sablon H., Caput D., Fradizeli D., Wollman E. E. Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter. Gene. 1994; 140: 273–278
- Li W. H., Tanimura M., Sahrp P. An evaluation of the molecular clock hypothesis using mammalian DNA sequences. J. Mol. Evol. 1987; 25: 333–342
- Spyrou G., Enmark E., Miranda-Vizuete A., Gustafsson J. Å. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 1997; 272: 2936–2941
- Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K., Yokota T., Wakasugi H., Yodoi J. ATL derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 1989; 8: 757–764
- Tonissen K. F., Wells J. R. E. Isolation and characterization of human thioredoxin-encoding genes. Gene. 1991; 102: 221–228
- Vanin E. Processed pseudogenes: characteristics and evolution. Annu. Rev. Genet. 1985; 19: 253–272